Pfizer Inc has received institutional review board approval to start a virtual clinical trial in the US that uses mobile telephone and web-based technology to collect data from participants rather than requiring them to visit clinics. ---Subscribe to MedNous to access this article--- Research & University News Regulation & Policy Company News
